Extent of disease in recurrent prostate cancer determined by [68Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score - Verburg, FA; Pfister, D; Heidenreich, A (Eur J Nucl Med Mol Imaging, 2015)
DOI